Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Baldini

Showing results (61-70 of 151) with videos related to

Pageof 16
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2003
Treatment of indolent B-Cell nonfollicular lymphomas: final results of the LL01 randomized trial of the Gruppo Italiano per lo Studio dei LinfomiLuca Baldini, Maura Brugiatelli, Stefano Luminari, et al.
Genes, Chromosomes & Cancer|December 12, 2013
Molecular events underlying interleukin-6 independence in a subclone of the CMA-03 multiple myeloma cell lineDonata Verdelli, Lucia Nobili, Katia Todoerti, et al.
Haematologica|August 13, 2013
Monocyte count at diagnosis is a prognostic parameter in diffuse large B-cell lymphoma: results from a large multicenter study involving 1191 patients in the pre- and post-rituximab eraTamar Tadmor, Alessia Bari, Stefano Sacchi, et al.
Hematological Oncology|March 9, 2019
A case report of systemic mastocytosis associated with multiple hematologic non-mast cell lineage diseasesFederica Irene Grifoni, Mariarita Sciumè, Valerio Pravettoni, et al.
International Journal of Cardiology|November 15, 2016
Exercise speckle-tracking strain imaging demonstrates impaired right ventricular contractile reserve in hypertrophic cardiomyopathyAntonello D'Andrea, Giuseppe Limongelli, Luca Baldini, et al.
British Journal of Haematology|August 16, 2002
Microvessel density, a surrogate marker of angiogenesis, is significantly related to survival in multiple myeloma patientsGiancarlo Pruneri, Maurilio Ponzoni, Andrés J M Ferreri, et al.
Mayo Clinic Proceedings|June 6, 2015
Absolute Monocyte Count and Lymphocyte-Monocyte Ratio Predict Outcome in Nodular Sclerosis Hodgkin Lymphoma: Evaluation Based on Data From 1450 PatientsTamar Tadmor, Alessia Bari, Luigi Marcheselli, et al.
Cancers|May 28, 2020
Application of Next-Generation Sequencing for the Genomic Characterization of Patients with Smoldering MyelomaMartina Manzoni, Valentina Marchica, Paola Storti, et al.
European Journal of Haematology|February 3, 2006
The length of treatment of aggressive non-Hodgkin's lymphomas established according to the international prognostic index score: long-term results of the GISL LA03 studyMassimo Federico, Stefano Luminari, Paolo G Gobbi, et al.
Cancer|December 20, 2011
Fludarabine, cyclophosphamide, and rituximab in patients with advanced, untreated, indolent B-cell nonfollicular lymphomas: phase 2 study of the Italian Lymphoma FoundationAndrea Ferrario, Alessandro Pulsoni, Barbara Olivero, et al.
Pageof 16

Showing results (61-70 of 151) with videos related to

Sort By:
Pageof 16
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2003
Treatment of indolent B-Cell nonfollicular lymphomas: final results of the LL01 randomized trial of the Gruppo Italiano per lo Studio dei LinfomiLuca Baldini, Maura Brugiatelli, Stefano Luminari, et al.
Genes, Chromosomes & Cancer|December 12, 2013
Molecular events underlying interleukin-6 independence in a subclone of the CMA-03 multiple myeloma cell lineDonata Verdelli, Lucia Nobili, Katia Todoerti, et al.
Haematologica|August 13, 2013
Monocyte count at diagnosis is a prognostic parameter in diffuse large B-cell lymphoma: results from a large multicenter study involving 1191 patients in the pre- and post-rituximab eraTamar Tadmor, Alessia Bari, Stefano Sacchi, et al.
Hematological Oncology|March 9, 2019
A case report of systemic mastocytosis associated with multiple hematologic non-mast cell lineage diseasesFederica Irene Grifoni, Mariarita Sciumè, Valerio Pravettoni, et al.
International Journal of Cardiology|November 15, 2016
Exercise speckle-tracking strain imaging demonstrates impaired right ventricular contractile reserve in hypertrophic cardiomyopathyAntonello D'Andrea, Giuseppe Limongelli, Luca Baldini, et al.
British Journal of Haematology|August 16, 2002
Microvessel density, a surrogate marker of angiogenesis, is significantly related to survival in multiple myeloma patientsGiancarlo Pruneri, Maurilio Ponzoni, Andrés J M Ferreri, et al.
Mayo Clinic Proceedings|June 6, 2015
Absolute Monocyte Count and Lymphocyte-Monocyte Ratio Predict Outcome in Nodular Sclerosis Hodgkin Lymphoma: Evaluation Based on Data From 1450 PatientsTamar Tadmor, Alessia Bari, Luigi Marcheselli, et al.
Cancers|May 28, 2020
Application of Next-Generation Sequencing for the Genomic Characterization of Patients with Smoldering MyelomaMartina Manzoni, Valentina Marchica, Paola Storti, et al.
European Journal of Haematology|February 3, 2006
The length of treatment of aggressive non-Hodgkin's lymphomas established according to the international prognostic index score: long-term results of the GISL LA03 studyMassimo Federico, Stefano Luminari, Paolo G Gobbi, et al.
Cancer|December 20, 2011
Fludarabine, cyclophosphamide, and rituximab in patients with advanced, untreated, indolent B-cell nonfollicular lymphomas: phase 2 study of the Italian Lymphoma FoundationAndrea Ferrario, Alessandro Pulsoni, Barbara Olivero, et al.
Pageof 16